(MENAFN- GlobeNewsWire - Nasdaq) AI-Driven Retinal Screening Devices Revolutionize U.S. Eye Care: Boosted by Diabetic Retinopathy Detection, Aging Population, and Tech Innovations

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets's offering.
The U.S. AI-Driven Retinal Screening Device Market was valued at USD 851.4 million in 2024 and is estimated to grow at a CAGR of 11.7% to reach USD 2.6 billion by 2034.
The market is fueled by the rising prevalence of diabetic retinopathy and age-related eye conditions, advancements in deep learning and image recognition, and growing awareness around early eye disease detection. The expanding geriatric population and increasing emphasis on preventive eye care are further accelerating adoption.

AI-enabled retinal screening systems deliver rapid, reliable evaluations of retinal abnormalities, and their integration into ophthalmology clinics, primary care centers, pharmacies, and mobile units is improving access to advanced eye diagnostics. As healthcare shifts toward proactive, technology-driven eye care, AI-based screening tools are increasingly essential for detecting retinal conditions early and enhancing patient outcomes across diverse care settings.

Recent innovations in deep learning have significantly enhanced the precision and efficiency of image-based diagnostics. AI algorithms can identify subtle retinal changes often missed by human observation, enabling earlier, more accurate diagnoses. These systems continuously improve through learning algorithms, increasing their effectiveness over time.
The diabetic retinopathy segment generated USD 461.7 million in 2024. AI-driven screening is transforming diabetic retinopathy diagnosis by enabling early, autonomous assessments in primary care environments. These systems analyze retinal images for microaneurysms, hemorrhages, and other disease indicators, often reducing the need for specialist reviews and accelerating treatment initiation.
The hospitals segment held 50.6% share in 2024, benefiting from high patient volumes and the capacity to invest in advanced technology. Hospitals are deploying AI retinal screening devices to streamline diagnostics, enhance efficiency, and reduce specialist workloads, particularly during routine examinations and chronic disease management programs.
South Atlantic AI-Driven Retinal Screening Device Market held a 19.6% share in 2024. States in this zone are witnessing strong uptake due to a sizable elderly population and high diabetes prevalence. Healthcare providers are integrating AI retinal screening into primary care and community clinics to support early detection and alleviate pressure on specialists. Telehealth adoption and mobile screening units are also expanding, making AI solutions critical for preventive eye care, especially in underserved areas.
Key players in the U.S. AI-Driven Retinal Screening Device Market include Topcon Healthcare, Visionix, EYENUK, DIGITAL DIAGNOSTICS, AEYE Health, Notal Vision, iCare, Remidio, Evolucare, Optomed, and Forus Health. Companies in the U.S. AI-Driven Retinal Screening Device Market are adopting several strategies to strengthen their foothold.

They are investing in research and development to enhance AI algorithms for improved diagnostic accuracy and broader disease detection. Strategic partnerships with healthcare providers, telemedicine platforms, and technology firms expand market reach and integration. Firms are also focusing on training programs for clinicians and technicians to ensure seamless adoption. Product diversification, mobile and cloud-based solutions, and targeted marketing campaigns help increase accessibility and awareness.
Comprehensive Market Analysis and Forecast

• Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
• Competitive landscape with Porter's Five Forces and PESTEL analysis
• Market size, segmentation, and regional forecasts
• In-depth company profiles, business strategies, financial insights, and SWOT analysis

Key Attributes:

Report Attribute	Details
No. of Pages	140
Forecast Period	2024 - 2034
Estimated Market Value (USD) in 2024	$851.4 Million
Forecasted Market Value (USD) by 2034	$2600 Million
Compound Annual Growth Rate	11.7%
Regions Covered	United States

Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of diabetic retinopathy and age-related eye diseases
3.2.1.2 Rise in awareness and demand for early diagnosis in ophthalmology
3.2.1.3 Supportive regulatory environment for AI in healthcare
3.2.1.4 Advancements in deep learning and image recognition technologies
3.2.2 Industry pitfalls and challenges
3.2.2.1 Data privacy and security concerns
3.2.2.2 High initial implementation cost
3.2.3 Opportunities
3.2.3.1 Development of portable and smartphone-based screening tools
3.2.3.2 AI-powered predictive analytics for disease progression
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology and innovation landscape
3.5.1 Current technological trends
3.5.2 Emerging technologies
3.6 Investment landscape
3.7 Reimbursement scenario
3.8 Technology evolution timeline
3.9 Impact of AI on clinical workflows and decision-making
3.10 Deployment model outlook
3.11 Emerging use cases & applications
3.11.1 Systemic disease screening from retinal images
3.11.2 Cardiovascular risk assessment
3.11.3 Neurological condition detection
3.12 Value chain analysis
3.12.1 Hardware manufacturers
3.12.2 AI algorithm developers
3.12.3 Software platform providers
3.12.4 Healthcare service providers
3.12.5 End-user integration partners
3.13 Porter's analysis
3.14 PESTEL analysis
3.15 Gap analysis
3.16 Future market trends
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Key developments
4.6.1 Mergers & acquisitions
4.6.2 Partnerships & collaborations
4.6.3 New product launches
4.6.4 Expansion plans
Chapter 5 Market Estimates and Forecast, by Technology, 2021-2034 ($ Mn)
5.1 Key trends
5.2 Fundus image-based AI
5.3 OCT-based AI
5.4 Multi-modal AI
Chapter 6 Market Estimates and Forecast, by Application, 2021-2034 ($ Mn)
6.1 Key trends
6.2 Diabetic retinopathy
6.3 Age-related macular degeneration
6.4 Glaucoma
6.5 Cataract
6.6 Other applications
Chapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ophthalmology clinics
7.4 Mobile clinics/Rural camps
7.5 Other end use
Chapter 8 Market Estimates and Forecast, by Zone, 2021-2034 ($ Mn)
8.1 Key trends
8.2 East North Central
8.2.1 Illinois
8.2.2 Indiana
8.2.3 Michigan
8.2.4 Ohio
8.2.5 Wisconsin
8.3 West South Central
8.3.1 Arkansas
8.3.2 Louisiana
8.3.3 Oklahoma
8.3.4 Texas
8.4 South Atlantic
8.4.1 Delaware
8.4.2 Florida
8.4.3 Georgia
8.4.4 Maryland
8.4.5 North Carolina
8.4.6 South Carolina
8.4.7 Virginia
8.4.8 West Virginia
8.4.9 Washington, D.C.
8.5 Northeast
8.5.1 Connecticut
8.5.2 Maine
8.5.3 Massachusetts
8.5.4 New Hampshire
8.5.5 Rhode Island
8.5.6 Vermont
8.5.7 New Jersey
8.5.8 New York
8.5.9 Pennsylvania
8.6 East South Central
8.6.1 Alabama
8.6.2 Kentucky
8.6.3 Mississippi
8.6.4 Tennessee
8.7 West North Central
8.7.1 Iowa
8.7.2 Kansas
8.7.3 Minnesota
8.7.4 Missouri
8.7.5 Nebraska
8.7.6 North Dakota
8.7.7 South Dakota
8.8 Pacific Central
8.8.1 Alaska
8.8.2 California
8.8.3 Hawaii
8.8.4 Oregon
8.8.5 Washington
8.9 Mountain States
8.9.1 Arizona
8.9.2 Colorado
8.9.3 Utah
8.9.4 Nevada
8.9.5 New Mexico
8.9.6 Idaho
8.9.7 Montana
8.9.8 Wyoming
Chapter 9 Company Profiles
9.1 AEYE Health
9.2 DIGITAL DIAGNOSTICS
9.3 evolucare
9.4 EYENUK
9.5 Forus Health
9.6 iCare
9.7 NOTAL VISION
9.8 OPTOMED
9.9 remidio
9.10 Topcon Healthcare
9.11 Visionix

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• U.S. AI-Driven Retinal Screening Device Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN05122025004107003653ID1110441986